What is the share price of Dr. Agarwal's Health Care Ltd (AGARWALEYE) today?
The share price of AGARWALEYE as on 23rd March 2026 is ₹415.35. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dr. Agarwal's Health Care Ltd (AGARWALEYE) share?
The past returns of Dr. Agarwal's Health Care Ltd (AGARWALEYE) share are- Past 1 week: -1.60%
- Past 1 month: -4.68%
- Past 3 months: -15.31%
- Past 6 months: -6.82%
- Past 1 year: -2.20%
- Past 3 years: N/A%
- Past 5 years: 5.65%
What are the peers or stocks similar to Dr. Agarwal's Health Care Ltd (AGARWALEYE)?
The peers or stocks similar to Dr. Agarwal's Health Care Ltd (AGARWALEYE) include:What is the market cap of Dr. Agarwal's Health Care Ltd (AGARWALEYE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr. Agarwal's Health Care Ltd (AGARWALEYE) is ₹13416.80 Cr as of 23rd March 2026.What is the 52 week high and low of Dr. Agarwal's Health Care Ltd (AGARWALEYE) share?
The 52-week high of Dr. Agarwal's Health Care Ltd (AGARWALEYE) is ₹568 and the 52-week low is ₹327.What is the PE and PB ratio of Dr. Agarwal's Health Care Ltd (AGARWALEYE) stock?
The P/E (price-to-earnings) ratio of Dr. Agarwal's Health Care Ltd (AGARWALEYE) is 160.76. The P/B (price-to-book) ratio is 6.96.Which sector does Dr. Agarwal's Health Care Ltd (AGARWALEYE) belong to?
Dr. Agarwal's Health Care Ltd (AGARWALEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Dr. Agarwal's Health Care Ltd (AGARWALEYE) shares?
You can directly buy Dr. Agarwal's Health Care Ltd (AGARWALEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dr. Agarwal's Health Care Ltd
AGARWALEYE Share Price
NSE₹415.352.12% (-9.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
AGARWALEYE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
AGARWALEYE Performance & Key Metrics
AGARWALEYE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 106.44 | 6.96 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.10 | 5.54 | 0.61% |
67%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
AGARWALEYE Company Profile
Dr. Agarwal's Health Care Ltd operates eye care hospitals and provides a comprehensive range of eye care services, including surgeries, consultations, and optical products.
APOLLOHOSP
PE Ratio
72.12
72.12
1Y Return
13.75%
13.75%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
86.21
86.21
1Y Return
15.06%
15.06%
Buy Reco %
81.82
81.82
FORTIS
PE Ratio
79.80
79.80
1Y Return
31.04%
31.04%
Buy Reco %
82.35
82.35
PE Ratio
42.37
42.37
1Y Return
1.99%
1.99%
Buy Reco %
80.00
80.00
ASTERDM
PE Ratio
6.12
6.12
1Y Return
44.64%
44.64%
Buy Reco %
100.00
100.00
AGARWALEYE Sentiment Analysis
AGARWALEYE Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AGARWALEYE Stock Summary · February 2026
The company demonstrated robust financial performance in the third quarter, marked by significant year-on-year growth in total income and improved EBITDA margins, reflecting effective cost management and operational efficiency. However, challenges persist, particularly with declining revenue per facility and initial losses from newly launched centers, which have raised concerns about long-term sustainability. Despite these hurdles, the company is aggressively expanding its network, with a focus on underserved markets and strategic investments in advanced surgical technologies, which are driving revenue growth, especially in high-end procedures. The ongoing merger process and exploration of new markets, such as Ethiopia, further underscore a commitment to long-term growth and operational scaling, even as management remains vigilant about regional market dynamics. Overall, while the company faces certain operational challenges, its proactive approach to expansion and investment positions it well for future profitability.
AGARWALEYE Stock Growth Drivers
AGARWALEYE Stock Growth Drivers
7Strong Financial Performance
The company reported significant financial achievements, including a total income of Rs. 1,548 crores for
Operational Growth and Patient Engagement
The company served over 22 lakh patients and performed nearly 238,283 surgeries during the nine
AGARWALEYE Stock Challenges
AGARWALEYE Stock Challenges
4Decline in Revenue per Facility
The company has experienced a decline in revenue per facility over the past nine months,
Greenfield Losses
The company reported cumulative Greenfield losses of Rs. 28.5 crores over the past three years,
AGARWALEYE Forecast
AGARWALEYE Forecasts
Price
Revenue
Earnings
AGARWALEYE Share Price Forecast
AGARWALEYE Share Price Forecast
2026
Current
₹424.35
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹424.35
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
AGARWALEYE Company Revenue Forecast
AGARWALEYE Company Revenue Forecast
2025
Current
₹1.76
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.76
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
AGARWALEYE Stock EPS (Earnings Per Share) Forecast
AGARWALEYE Stock EPS (Earnings Per Share) Forecast
2025
Current
₹5.13
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹5.13
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
AGARWALEYE
AGARWALEYE
Income
Balance Sheet
Cash Flow
Quarterly Normal View
AGARWALEYE Income Statement
AGARWALEYE Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 344.69 | 369.07 | 409.49 | 428.45 | 443.43 | 475.65 | 500.81 | 506.62 | 540.40 | |||||||||
Operating & Other expenses | 243.71 | 240.81 | 299.87 | 309.60 | 315.91 | 331.73 | 359.56 | 362.55 | 385.76 | |||||||||
EBITDA | 100.98 | 128.26 | 109.62 | 118.85 | 127.52 | 143.92 | 141.25 | 144.07 | 154.64 | |||||||||
| Depreciation/Amortization | 42.57 | 46.70 | 55.51 | 57.18 | 58.18 | 60.39 | 62.95 | 67.86 | 68.75 | |||||||||
| PBIT | 58.41 | 81.56 | 54.11 | 61.67 | 69.34 | 83.53 | 78.30 | 76.21 | 85.89 | |||||||||
| Interest & Other Items | 22.39 | 27.39 | 27.03 | 28.40 | 28.35 | 25.01 | 24.70 | 22.55 | 21.13 | |||||||||
| PBT | 36.02 | 54.17 | 27.08 | 33.27 | 40.99 | 58.52 | 53.60 | 53.66 | 64.76 | |||||||||
| Taxes & Other Items | 16.21 | 15.42 | 15.10 | 16.69 | 18.65 | 25.95 | 23.55 | 23.97 | 31.02 | |||||||||
| Net Income | 19.81 | 38.75 | 11.98 | 16.58 | 22.34 | 32.57 | 30.05 | 29.69 | 33.74 | |||||||||
| EPS | 1.94 | 1.39 | 0.43 | 0.45 | 0.73 | 1.04 | 0.95 | 0.94 | 1.07 |
AGARWALEYE Company Updates
FY 2026FY 2026
Investor Presentation
Feb 3PDF
Oct 31PDF
Aug 12PDF
AGARWALEYE Stock Peers
AGARWALEYE Past Performance & Peer Comparison
AGARWALEYE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dr. Agarwal's Health Care Ltd | 160.76 | 6.96 | — |
| Apollo Hospitals Enterprise Ltd | 72.12 | 9.40 | 0.17% |
| Max Healthcare Institute Ltd | 86.21 | 9.89 | 0.16% |
| Fortis Healthcare Ltd | 79.80 | 6.74 | 0.12% |
AGARWALEYE Stock Price Comparison
Compare AGARWALEYE with any stock or ETFCompare AGARWALEYE with any stock or ETF
AGARWALEYE
AGARWALEYE Holdings
AGARWALEYE Shareholdings
AGARWALEYE Promoter Holdings Trend
AGARWALEYE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AGARWALEYE Institutional Holdings Trend
AGARWALEYE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
AGARWALEYE Shareholding Pattern
AGARWALEYE Shareholding Pattern
AGARWALEYE Shareholding History
AGARWALEYE Shareholding History
Foreign Institutions
Mutual Funds Invested in AGARWALEYE
Mutual Funds Invested in AGARWALEYE
No mutual funds holding trends are available
Top 5 Mutual Funds holding Dr. Agarwal's Health Care Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.3389% | Percentage of the fund’s portfolio invested in the stock 3.18% | Change in the portfolio weight of the stock over the last 3 months -1.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/63 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1801% | Percentage of the fund’s portfolio invested in the stock 1.21% | Change in the portfolio weight of the stock over the last 3 months -0.10% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/86 (-10) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0323% | Percentage of the fund’s portfolio invested in the stock 1.07% | Change in the portfolio weight of the stock over the last 3 months -0.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/105 (+23) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing AGARWALEYE stock
smallcases containing AGARWALEYE stock
Looks like this stock is not in any smallcase yet.
AGARWALEYE Events
AGARWALEYE Events
AGARWALEYE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AGARWALEYE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
AGARWALEYE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AGARWALEYE has not given any dividends in last 5 years
AGARWALEYE Dividends
AGARWALEYE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAGARWALEYE Stock News & Opinions
AGARWALEYE Stock News & Opinions
Articles & Videos
Earnings
Dr Agarwal's Health Care consolidated net profit rises 51.03% in the December 2025 quarter
Net profit of Dr Agarwal's Health Care rose 51.03% to Rs 33.74 crore in the quarter ended December 2025 as against Rs 22.34 crore during the previous quarter ended December 2024. Sales rose 23.02% to Rs 529.86 crore in the quarter ended December 2025 as against Rs 430.72 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales529.86430.72 23 OPM %27.2026.66 - PBDT133.5199.17 35 PBT64.7640.99 58 NP33.7422.34 51 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Dr Agarwals Health Care to convene board meeting
Dr Agarwals Health Care will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Dr Agarwal's Health Care to convene board meeting
Dr Agarwal's Health Care will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Dr Agarwals Health Care allots 3.37 lakh equity shares under ESOS
Dr Agarwals Health Care has allotted 3,37,504 equity shares under ESOS on 06 January 2026. Post allotment, the paid up equity share capital has increased to Rs 31,68,07,506 consisting of 31,68,07,506 equity shares of Re 1 each. Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Dr Agarwal's Health Care consolidated net profit rises 79.07% in the September 2025 quarter
Net profit of Dr Agarwal's Health Care rose 79.07% to Rs 29.69 crore in the quarter ended September 2025 as against Rs 16.58 crore during the previous quarter ended September 2024. Sales rose 19.71% to Rs 498.69 crore in the quarter ended September 2025 as against Rs 416.57 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales498.69416.57 20 OPM %27.3025.68 - PBDT121.5290.45 34 PBT53.6633.27 61 NP29.6916.58 79 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Dr Agarwals Health Care to hold board meeting
Dr Agarwals Health Care will hold a meeting of the Board of Directors of the Company on 30 October 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Dr Agarwal's Health Care to hold board meeting
Dr Agarwal's Health Care will hold a meeting of the Board of Directors of the Company on 30 October 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Dr Agarwals Health Care to convene AGM
Dr Agarwals Health Care announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Dr Agarwal's Health Care to convene AGM
Dr Agarwal's Health Care announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Dr Agarwal's Health Care consolidated net profit rises 150.83% in the June 2025 quarter
Net profit of Dr Agarwal's Health Care rose 150.83% to Rs 30.05 crore in the quarter ended June 2025 as against Rs 11.98 crore during the previous quarter ended June 2024. Sales rose 20.80% to Rs 487.42 crore in the quarter ended June 2025 as against Rs 403.49 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales487.42403.49 21 OPM %26.2325.68 - PBDT116.5582.59 41 PBT53.6027.08 98 NP30.0511.98 151 Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 26.44%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 1.3% to 2.13%